Business Context and Reporting Period
This Form 8-K Current Report was filed by Protagonist Therapeutics, Inc. on August 16, 2016. The report documents corporate governance actions taken in connection with the closing of the Company's initial public offering (IPO) of common stock.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal and corporate structural changes rather than financial performance data.
Material Changes
- Amended and Restated Certificate of Incorporation: Filed with the Delaware Secretary of State on August 16, 2016, effective upon the consummation of the IPO.
- Amended and Restated Bylaws: Adopted effective August 16, 2016, in connection with the IPO closing.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors. It serves as a notification of the adoption of new corporate charter documents required for the Company's transition to a publicly traded entity.
Key Facts for Investor Verification
- Confirm the closing date and terms of the initial public offering referenced in the Form S-1 (File No. 333-212476).
- Review the attached Amended and Restated Certificate of Incorporation (Exhibit 3.1) for changes to authorized share capital or director structure.
- Review the attached Amended and Restated Bylaws (Exhibit 3.2) for governance rules applicable to public shareholders.